Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery

Clinical trial NCT06617897 · RECRUITING

Trial details

NCT number: NCT06617897
Sponsor: CSL Behring
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acquired Fibrinogen Deficiency

Start date: 2024-10-01
Primary completion: 2027-09-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.